Download PDF
Klin Padiatr 2012; 224(06): 386-389
DOI: 10.1055/s-0032-1323836
Case Report
© Georg Thieme Verlag KG Stuttgart · New York

Fatal EBV Infection and Variable Clinical Manifestations in an XLP-1 Pedigree – Rapid Diagnosis of Primary Immunodeficiencies may Save Lives

Fatale EBV-Infektionen und andere klinische Manifestationen in einer XLP-1 Familie – Familienanamnese und schnelle Diagnose können Leben retten
D. Sperl
1   Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Austria
,
M. Benesch
1   Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Austria
,
C. Urban
1   Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Austria
,
H. Lackner
1   Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Austria
,
P. Sovinz
1   Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Austria
,
M. R. Speicher
2   Institut für Humangenetik, Medizinische Universität Graz, Graz, Austria
,
S. Uhrig
2   Institut für Humangenetik, Medizinische Universität Graz, Graz, Austria
,
T. Schwarzbraun
2   Institut für Humangenetik, Medizinische Universität Graz, Graz, Austria
,
W. Schwinger
1   Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Austria
,
U. zur Stadt
3   Klinik und Poliklinik für pädiatrische Hämatologie and Onkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
,
K. Beutel
3   Klinik und Poliklinik für pädiatrische Hämatologie and Onkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
,
G. Janka
3   Klinik und Poliklinik für pädiatrische Hämatologie and Onkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
,
M. Scarpatetti
4   Institut für Pathologie, Medizinische Universität Graz, Graz, Austria
,
M. G Seidel
1   Pädiatrische Hämatologie-Onkologie, Universitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Austria
› Author Affiliations
Further Information

Publication History

Publication Date:
09 November 2012 (online)

Also available at
    Permissions and Reprints

Abstract

Two related boys who died from fulminant infectious mononucleosis were diagnosed with X-linked lymphoproliferative disease type 1 (XLP-1). Family screening (n=17) identified 6 female mutation carriers and 2 more XLP-1 patients in whom, despite recurrent infections, agammaglobulinemia, and Hodgkin’s Disease, the genetic basis had been unknown; demonstrating that awareness and early genetic testing are crucial to reveal underlying primary immunodeficiencies and improve outcome. Furthermore, XLP should be included routinely in the differential diagnosis of severe hypogammaglobulinemia and/or lymphoma in males.

Zusammenfassung

Zwei verwandte Buben verstarben innerhalb von 4 Monaten an fulminant verflaufender infektiöser Mononukleose (FIM). Die genetische Diagnostik ergab eine X-linked lymphoproliferative Erkrankung Typ 1 (XLP-1); im Familienscreening wurden 6 weibliche Mutationsträgerinnen und 2 weitere männliche XLP-1 Patienten mit rezidivierenden Infektionen, Agammaglobulinämie und Hodgkin Lymphom identifiziert. Diese XLP-1 Krankheitsverläufe demonstrieren, dass nicht nur bei FIM an zugrundeliegende Immundefizienzen wie XLP gedacht werden sollte.

Key words

EBV infection - lymphoproliferative disease - primary immunodeficiency - family screening - genetic counselling - hemophagocytic lymphohistiocytosis

Supplementary Material

 

  • References

  • 1 Airas L, Paivarinta M, Roytta M et al. Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT. Bone Marrow Transplant 2010; 45: 593-596
    CrossrefPubMedGoogle Scholar
  • 2 Booth C, Gilmour KC, Veys P et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 2011; 117: 53-62
    CrossrefPubMedGoogle Scholar
  • 3 Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93: 190-197
    CrossrefPubMedGoogle Scholar
  • 4 de Vries E. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol 2012; 167: 108-119
    CrossrefPubMedGoogle Scholar
  • 5 Dong Z, Veillette A. How do SAP family deficiencies compromise immunity?. Trends Immunol 2010; 31: 295-302
    CrossrefPubMedGoogle Scholar
  • 6 Farmand S, Baumann U, von Bernuth H et al. Interdisciplinary AWMF guideline for the diagnostics of primary immunodeficiency. Klin Padiatr 2011; 223: 378-385
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Filipovich AH, Zhang K, Snow AL et al. X-linked lymphoproliferative syndromes: brothers or distant cousins?. Blood 2010; 116: 3398-3408
    CrossrefPubMedGoogle Scholar
  • 8 Grierson HL, Skare J, Hawk J et al. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Am J Med Genet 1991; 40: 294-297
    CrossrefPubMedGoogle Scholar
  • 9 Gross TG, Filipovich AH, Conley ME et al. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996; 17: 741-744
    PubMedGoogle Scholar
  • 10 Henter JI, Horne A, Arico M et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131
    CrossrefPubMedGoogle Scholar
  • 11 Honig M, Schulz A, Friedrich W. Hematopoietic stem cell transplantation for severe combined immunodeficiency. Klin Padiatr 2011; 223: 320-325
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Huck K, Feyen O, Niehues T et al. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest 2009; 119: 1350-1358
    CrossrefPubMedGoogle Scholar
  • 13 Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr 2009; 221: 278-285
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Lankester AC, Visser LF, Hartwig NG et al. Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature. Bone Marrow Transplant 2005; 36: 99-105
    CrossrefPubMedGoogle Scholar
  • 15 Marsh RA, Bleesing JJ, Filipovich AH. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. J Immunol Methods 2010; 362: 1-9
    CrossrefPubMedGoogle Scholar
  • 16 Morra M, Simarro-Grande M, Martin M et al. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients. J Biol Chem 2001; 276: 36809-36816
    CrossrefPubMedGoogle Scholar
  • 17 Pachlopnik Schmid J, Canioni D, Moshous D et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood 2011; 117: 1522-1529
    CrossrefPubMedGoogle Scholar
  • 18 Purtilo DT, Cassel C, Yang JP. Letter: Fatal infectious mononucleosis in familial lymphohistiocytosis. N Engl J Med 1974; 291: 736
    PubMedGoogle Scholar
  • 19 Purtilo DT, Szymanski I, Bhawan J et al. Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome. Lancet 1978; 1: 798-801
    PubMedGoogle Scholar
  • 20 Rigaud S, Fondaneche MC, Lambert N et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006; 444: 110-114
    CrossrefPubMedGoogle Scholar
  • 21 Salzer E, Daschkey S, Choo S et al. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica 2012; July 16 [epub ahead of print]
    PubMedGoogle Scholar
  • 22 Schuster V, Grimm T, Kress W et al. X-chromosome recessive lymphoproliferative disease (XLP): molecular genetic studies. Klin Padiatr 1995; 207: 271-276
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Seidel MG. CD27: A new player in the field of common variable immunodeficiency and EBV-associated lymphoproliferative disorder?. J Allergy Clin Immunol 2012; 129: 1175
    PubMedGoogle Scholar
  • 24 Sumegi J, Huang D, Lanyi A et al. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood 2000; 96: 3118-3125
    PubMedGoogle Scholar
  • 25 Talaat KR, Rothman JA, Cohen JI et al. Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection. Pediatr Blood Cancer 2009; 53: 1120-1123
    CrossrefPubMedGoogle Scholar
  • 26 Tatsuo H, Ono N, Tanaka K et al. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406: 893-897
    CrossrefPubMedGoogle Scholar
  • 27 van Montfrans JM, Hoepelman AI, Otto S et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2011; 129: 787-793
    PubMedGoogle Scholar